Free Trial
NASDAQ:CWBR

CohBar (CWBR) Stock Price, News & Analysis

CohBar logo
$0.49
0.00 (0.00%)
(As of 10/31/2024 09:06 PM ET)

About CohBar Stock (NASDAQ:CWBR)

Key Stats

Today's Range
$0.49
$0.49
50-Day Range
$0.43
$0.53
52-Week Range
$0.00
$1.93
Volume
1,200 shs
Average Volume
2,420 shs
Market Capitalization
$1.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.

Receive CWBR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CohBar and its competitors with MarketBeat's FREE daily newsletter.

CWBR Stock News Headlines

Reviewing CohBar (NASDAQ:CWBR) & Keros Therapeutics (NASDAQ:KROS)
MOLY:CA Greenland Resources Inc.
Top 10 AI Stocks to Buy Now
Are you ready to capitalize on the booming AI market? Our experts have identified the top 10 AI stocks set to skyrocket.
CohBar, Inc. (CWBR)
CohBar Inc CWBR
See More Headlines

CWBR Stock Analysis - Frequently Asked Questions

CohBar's stock was trading at $0.74 at the beginning of the year. Since then, CWBR shares have decreased by 33.8% and is now trading at $0.49.
View the best growth stocks for 2024 here
.

CohBar, Inc. (NASDAQ:CWBR) issued its quarterly earnings results on Monday, November, 15th. The company reported ($1.50) EPS for the quarter, beating the consensus estimate of ($2.70) by $1.20.

CohBar shares reverse split on Friday, September 23rd 2022. The 1-30 reverse split was announced on Friday, September 23rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of CWBR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that CohBar investors own include ADMA Biologics (ADMA), Meta Platforms (META), 9 Meters Biopharma (NMTR), NVIDIA (NVDA), ObsEva (OBSV), Applied Genetic Technologies (AGTC) and Allena Pharmaceuticals (ALNA).

Company Calendar

Last Earnings
11/15/2021
Today
11/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CWBR
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$5.27 per share

Miscellaneous

Free Float
2,718,000
Market Cap
$1.43 million
Optionable
Not Optionable
Beta
1.37
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:CWBR) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners